[Thalidomide: the revival].
Grosbois
B
B
Duguet
C
C
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000494:pharmacology / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D007166:Immunosuppressive Agents; D013792:Thalidomide
Thalidomide: le renouveau.